Relaxoforce

Dosage for Coffea Arabica Seed, Roasted is not standardized by weight (mg) but rather by volume and concentration of the allergenic extract. The healthcare provider will determine the appropriate concentration based on the patient's clinical history and the method of testing.

• Percutaneous (Skin Prick) Testing: Usually, one drop of the 1:10 or 1:20 w/v (weight/volume) concentrated extract is applied to the skin (typically the forearm or back). A sterile lancet is then used to prick the skin through the drop.
• Intradermal Testing: If the skin prick test is negative but the clinical history strongly suggests an allergy, a more dilute solution (ranging from 1:100 to 1:1000 w/v) may be used. A volume of 0.02 to 0.05 mL is injected into the intradermal layer of the skin to create a small bleb.

Coffea Arabica Seed, Roasted extracts can be used in the pediatric population; however, the procedure must be performed with extreme caution.

• Infants and Children: Skin prick testing is generally preferred over intradermal testing in children due to the lower risk of systemic reactions. The dosage (one drop for SPT) remains the same, but the number of simultaneous tests may be limited to reduce the total allergen load. There is no specific age cutoff, but the clinical necessity must be weighed against the discomfort and risk of the procedure in very young children.

Renal Impairment

No dosage adjustments are required for patients with renal impairment, as the systemic absorption of the allergenic extract during diagnostic testing is minimal. However, the patient's overall health should be stable before testing.

Hepatic Impairment

No dosage adjustments are necessary for hepatic impairment. The metabolism of the biological proteins in the extract is not dependent on hepatic CYP450 pathways.

Elderly Patients

In elderly patients, skin reactivity may be diminished due to age-related changes in skin turgor and mast cell density. Healthcare providers may need to interpret 'borderline' results with caution. There is no specific dose adjustment, but the selection of testing sites should favor areas with better skin integrity.

This medication is never self-administered. It is exclusively for use by trained medical professionals in an office or hospital setting.

1. 1Preparation: The skin site (usually the volar surface of the forearm) is cleaned with alcohol and allowed to dry.
2. 2Controls: A positive control (histamine) and a negative control (saline/glycerin) are applied simultaneously to ensure the skin is capable of reacting and that the patient does not have 'dermatographism' (a condition where any touch causes a hive).
3. 3Application: The Coffea Arabica extract is applied. If multiple extracts are being tested, they must be spaced at least 2 to 5 cm apart to prevent overlapping reactions.
4. 4Observation: The patient must remain in the office for at least 15 to 30 minutes. The healthcare provider will measure the size of the wheal (the bump) and the flare (the redness) using a millimeter ruler.
5. 5Storage: The extract must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Potency can be lost if the product is frozen or left at room temperature for extended periods.

As this is a diagnostic test performed during a scheduled clinical visit, missed doses are not applicable in the traditional sense. If a testing appointment is missed, it should be rescheduled. If a patient is undergoing a series of tests, the timeline will be adjusted by the allergist.

An 'overdose' in the context of allergenic extracts refers to the administration of too much allergen or an inappropriately high concentration, which can trigger a systemic allergic reaction (anaphylaxis).

• Signs of Overdose/Systemic Reaction: Generalized flushing, itching (pruritus), hives (urticaria) away from the test site, swelling of the throat or tongue, wheezing, shortness of breath, rapid heart rate, or a drop in blood pressure.
• Emergency Measures: If a systemic reaction occurs, the immediate administration of epinephrine (1:1000) via intramuscular injection is the first-line treatment. Other measures include oxygen, intravenous fluids, antihistamines, and corticosteroids.

> Important: Follow your healthcare provider's instructions regarding the discontinuation of antihistamines before the test, as these medications can 'mask' the results and lead to a false-negative diagnosis.

Because Coffea Arabica Seed, Roasted extract is designed to elicit a local immune response, 'side effects' at the site of administration are expected and indicate a positive test result.

• Local Wheal and Flare: This is the most common occurrence. It feels like a mosquito bite—a raised, itchy bump surrounded by a patch of red skin. It typically appears within 15 minutes and resolves within 1 to 2 hours.
• Local Pruritus (Itching): Intense itching at the site of the skin prick or intradermal injection is very common. This is a direct result of histamine release in the skin.
• Local Erythema (Redness): Redness around the test site is a standard part of the inflammatory response.

• Delayed Local Reactions: Some patients may experience a 'late-phase' reaction where the test site becomes swollen, red, and painful 6 to 24 hours after the test. This is usually managed with cold compresses or topical corticosteroids.
• Persistent Itching: In some cases, the itchiness may last for several hours after the wheal has dissipated.
• Small Bruising: Especially with intradermal testing, a small bruise (ecchymosis) may form at the needle insertion site.

• Systemic Urticaria: Hives appearing on parts of the body far away from the test site (e.g., hives on the chest after a test on the arm).
• Vasovagal Response: Fainting or lightheadedness due to the anxiety of the needle prick or the sight of blood/needles, rather than the extract itself.
• Lymphangitis: Very rarely, red streaks may appear extending from the test site, indicating inflammation of the lymph vessels.

> Warning: Stop the procedure and call for emergency medical help immediately if you experience any of the following symptoms of anaphylaxis. While rare with skin prick testing, the risk is higher with intradermal testing.

• Respiratory Distress: Difficulty breathing, wheezing, or a feeling of tightness in the chest. This indicates bronchospasm or airway edema.
• Angioedema: Significant swelling of the lips, tongue, or throat that may interfere with swallowing or breathing.
• Hypotension (Shock): A sudden drop in blood pressure, which may manifest as extreme dizziness, confusion, or loss of consciousness.
• Generalized Anaphylaxis: A multi-system reaction that can include gastrointestinal cramping, vomiting, and a sense of 'impending doom.'

There are no known long-term side effects associated with a one-time diagnostic use of Coffea Arabica Seed, Roasted extract. Unlike medications taken daily, this extract does not accumulate in the body. If used repeatedly for immunotherapy (which is non-standard for coffee), the primary long-term risk would be the ongoing risk of systemic reactions during each administration.

While specific 'black box' labels vary by manufacturer, most allergenic extracts carry a prominent warning regarding the risk of Severe Systemic Early-Phase Reactions.

Summary of Warning: This product can cause severe life-threatening systemic reactions, including anaphylaxis. It must only be administered by physicians who are exceptionally experienced in the treatment of systemic allergic reactions and in a facility equipped with the necessary equipment and medication (including epinephrine) to treat such reactions. Patients must be observed for at least 30 minutes following administration. Patients with unstable asthma or those taking beta-blockers may be at increased risk of severe outcomes.

Report any unusual or persistent symptoms to your healthcare provider immediately. Even a 'mild' systemic symptom like itchy palms or a scratchy throat should be reported during the observation period.

Coffea Arabica Seed, Roasted allergenic extract is intended solely for diagnostic or immunotherapeutic use by qualified healthcare professionals. It is not for self-administration. The most critical safety consideration is the potential for an acute systemic allergic reaction, which can occur even in patients who have previously tolerated the test.

No FDA black box warnings for Coffea Arabica Seed, Roasted specifically, but it falls under the general class warning for all Allergenic Extracts. The class warning emphasizes that these products can cause anaphylaxis and should only be used in settings where emergency resuscitation is possible. The warning also notes that the potency of non-standardized extracts can vary between lots, requiring cautious 'bridging' when switching to a new vial.

• Anaphylaxis Risk: The risk is inherent to the product's mechanism. Patients with a history of severe reactions to very small amounts of coffee should be tested with extreme caution, starting with highly diluted prick tests before considering intradermal testing.
• Asthma Status: Patients with severe or unstable asthma are at a significantly higher risk for a fatal outcome if a systemic reaction occurs. Testing should be postponed if the patient is experiencing an asthma flare-up or if their FEV1 (forced expiratory volume) is significantly below their personal best.
• Skin Conditions: Testing should not be performed on skin areas affected by active dermatitis, eczema, or psoriasis, as these conditions can cause false-positive results or interfere with the interpretation of the wheal and flare.
• Beta-Blocker Use: Patients taking beta-blockers (medications for blood pressure or heart rhythm) may be resistant to the effects of epinephrine, the primary treatment for anaphylaxis. This makes a systemic reaction much more difficult to treat.

• Immediate Observation: The patient must be monitored visually and vital signs checked if they report feeling unwell for at least 30 minutes post-administration.
• Baseline Lung Function: For patients with a history of asthma, a baseline peak flow or spirometry measurement may be taken before testing.
• Skin Inspection: The test site must be inspected at the 15-20 minute mark for the primary reading and potentially later if a delayed reaction is suspected.

Generally, Coffea Arabica Seed, Roasted does not interfere with the ability to drive or operate machinery. However, if a patient experiences a vasovagal response (fainting) or a systemic reaction requiring medication like diphenhydramine (which causes drowsiness), they should not drive until the effects have completely resolved.

There is no direct chemical interaction between alcohol and the roasted coffee extract. However, alcohol consumption can cause vasodilation and may theoretically increase the rate of allergen absorption or exacerbate a systemic reaction. It is advisable to avoid alcohol for several hours before and after allergy testing.

Since this is a diagnostic test, 'discontinuation' refers to stopping the procedure. If a patient shows any signs of a systemic reaction during the application of multiple allergens, the test must be stopped immediately, the extract wiped off the skin, and emergency protocols initiated.

> Important: Discuss all your medical conditions, especially heart disease or respiratory issues, with your healthcare provider before starting Coffea Arabica Seed, Roasted testing.

There are no absolute drug-drug contraindications that make the extract 'toxic,' but several medications are contraindicated because they make the test unsafe or uninterpretable.

• Beta-Blockers (e.g., Metoprolol, Propranolol): These are relatively contraindicated. If a patient on a beta-blocker has a severe allergic reaction to the coffee extract, epinephrine may not work effectively, leading to refractory anaphylaxis. The risk-benefit ratio must be carefully evaluated.
• Recent Anaphylaxis: Testing should not be performed within 4 weeks of a systemic allergic reaction, as the patient may be in a 'refractory period' where skin tests are falsely negative, or they may be hyper-sensitized and at higher risk for another reaction.

• ACE Inhibitors (e.g., Lisinopril): Some evidence suggests ACE inhibitors may increase the severity of anaphylactic reactions or the risk of angioedema during allergenic exposure.
• Tricyclic Antidepressants (e.g., Amitriptyline): These medications have potent antihistamine properties. They can suppress the skin's response to the extract for up to 7-14 days, leading to a false-negative result.

• H1 Antihistamines (e.g., Loratadine, Cetirizine, Diphenhydramine): These are the most common cause of false-negative allergy tests. They directly block the H1 receptors that the extract's histamine release targets.
• Management: Stop first-generation antihistamines (e.g., Benadryl) 3 days before testing; stop second-generation antihistamines (e.g., Zyrtec, Claritin) at least 7 days before testing.
• H2 Antihistamines (e.g., Famotidine, Ranitidine): These can also modestly suppress the skin flare reaction.
• Management: Stop 24-48 hours before testing.
• Topical Corticosteroids: Applying steroid creams to the test site will suppress the local immune response.
• Management: Do not use topical steroids on the testing area for at least 2-3 weeks.

• Caffeine: While the extract contains coffee proteins, systemic caffeine consumption does not typically interfere with the skin prick test. However, it is best to avoid heavy caffeine intake on the morning of the test to ensure heart rate and blood pressure are at a stable baseline.
• Cross-Reactive Foods: Patients allergic to coffee may occasionally show cross-reactivity with other members of the Rubiaceae family or certain legumes, though this is clinically rare.

• High-Dose Vitamin C: Some studies suggest very high doses of Vitamin C may have a mild antihistamine effect, though the clinical significance for skin testing is likely low.
• St. John's Wort: May interact with medications used to treat anaphylaxis, though not directly with the coffee extract.

• Skin Prick Test Accuracy: The presence of the extract in the skin will interfere with any other skin-based diagnostic tests performed at the same site. It does not typically interfere with standard blood work (CBC, CMP), but it may temporarily elevate the total IgE count if a systemic reaction occurs.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for allergies, depression, or blood pressure.

Coffea Arabica Seed, Roasted extract must NEVER be used in the following circumstances:

1. 1History of Severe Anaphylaxis to Coffee: If a patient has a documented history of near-fatal anaphylaxis upon minimal exposure to coffee, skin testing (especially intradermal) may be too dangerous. In vitro (blood) testing is preferred.
2. 2Uncontrolled Asthma: Patients with an FEV1 < 70% of predicted or those with frequent exacerbations are at an unacceptable risk for fatal bronchospasm during a systemic reaction.
3. 3Active Skin Disease at Test Site: Conditions like generalized urticaria, severe eczema, or dermatographism make the test results impossible to interpret accurately.
4. 4Hypersensitivity to Extract Components: If a patient is known to be allergic to the preservatives in the extract (such as phenol or glycerin), the test should not be performed.

These conditions require a careful risk-benefit analysis by the specialist:

• Pregnancy: While not a direct toxin, the risk of a systemic reaction and subsequent fetal hypoxia (lack of oxygen) means elective allergy testing is usually postponed until after delivery.
• Beta-Blocker Therapy: As noted, this complicates the treatment of potential anaphylaxis.
• Age (Infants/Very Elderly): The immune system's reactivity may be less predictable, and the physical stress of a systemic reaction is harder to manage.
• Cardiovascular Disease: Patients with unstable angina or recent myocardial infarction may not tolerate the stress of a systemic reaction or the epinephrine required to treat it.

Patients who react to Coffea Arabica Seed, Roasted may also react to:

• Green Coffee Bean Extract: Though roasting changes the proteins, some 'pan-allergens' may remain.
• Other Rubiaceae species: Though rare, botanical relatives could theoretically cause cross-reactions.

> Important: Your healthcare provider will evaluate your complete medical history and current health status before deciding to proceed with Coffea Arabica Seed, Roasted testing.

FDA Pregnancy Category C (or equivalent under current labeling): There are no adequate and well-controlled studies of Coffea Arabica Seed, Roasted extract in pregnant women. Animal reproduction studies have not been conducted.

• Risk Summary: The primary risk to the fetus is not the extract itself, but the potential for maternal anaphylaxis. A severe allergic reaction can lead to maternal hypotension and uterine hypoperfusion, resulting in fetal distress or even loss.
• Clinical Recommendation: Most allergists recommend postponing diagnostic skin testing with food extracts until after the pregnancy is complete, unless the information is critical for the immediate management of the mother's health.

It is not known whether the components of Coffea Arabica Seed, Roasted extract are excreted in human milk.

• Risk-Benefit: Because the amount of allergen used in skin testing is miniscule and local, it is highly unlikely to reach the breast milk in any detectable quantity. However, the mother's stress and any medications used to treat a reaction (like antihistamines) could potentially affect the nursing infant.
• Recommendation: Testing is generally considered safe during breastfeeding, but the mother should discuss the timing with her healthcare provider.

• Safety: Skin prick testing is widely used in children and is considered safe when performed by experts.
• Considerations: Children have thinner skin and may show more robust reactions than adults. The psychological impact of 'needles' should be managed with appropriate child-life techniques.
• Efficacy: The predictive value of a positive skin test for coffee in children must be correlated with a clear clinical history, as 'sensitization' (a positive test) does not always mean 'clinical allergy' (symptoms upon eating).

• Pharmacokinetics: Aging skin has fewer mast cells and reduced vascular responsiveness, which can lead to smaller wheal sizes.
• Safety: Older adults are more likely to have underlying cardiovascular disease, making them more vulnerable to the effects of a systemic reaction or the epinephrine used to treat it.
• Polypharmacy: The high prevalence of beta-blocker and ACE inhibitor use in the elderly requires careful medication screening before testing.

Renal impairment does not significantly affect the local IgE-mediated response. No specific adjustments are needed, but patients with end-stage renal disease (ESRD) may have uremic pruritus (itching), which can make the interpretation of an allergy test difficult.

There is no evidence that hepatic impairment alters the response to allergenic extracts. The proteins are degraded locally and do not rely on the liver for clearance.

> Important: Special populations require an individualized medical assessment to ensure that the diagnostic benefits of testing outweigh the potential risks of a systemic reaction.

Coffea Arabica Seed, Roasted extract acts as a specific antigen that triggers a Type I hypersensitivity reaction in individuals who have pre-existing IgE antibodies against coffee proteins. The roasted seed contains several proteins, including 11S storage proteins and various Maillard reaction products created during the heating process.

Upon administration, these allergens bind to the Fab portion of specific IgE molecules. These IgE molecules are 'loaded' onto high-affinity FceRI receptors on the surface of mast cells in the skin. The binding of the allergen causes 'cross-linking' of the receptors, which activates an intracellular signaling cascade involving tyrosine kinases (like Syk). This leads to the influx of calcium and the exocytosis of pre-formed granules containing histamine, heparin, and proteases. This is followed by the de novo synthesis of lipid mediators (prostaglandins and leukotrienes) and cytokines.

• Dose-Response: There is a clear dose-response relationship; higher concentrations of the extract will generally produce larger wheals in sensitized individuals.
• Time to Onset: The 'early-phase' reaction (wheal and flare) peaks at 15-20 minutes.
• Duration of Effect: The visible wheal typically disappears within 1-2 hours, though the underlying cellular activation can persist, leading to a late-phase reaction in some patients 6-12 hours later.
• Tolerance: Repeated exposure to the allergen (as in immunotherapy) can eventually lead to the production of 'blocking antibodies' (IgG4) and a shift from a Th2 to a Th1 immune response, reducing sensitivity.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (Percutaneous) |

| Protein Binding | Specific to IgE/IgG4 |

| Half-life | Localized; degraded within hours |

| Tmax (Skin Reaction) | 15 - 20 minutes |

| Metabolism | Proteolytic degradation |

| Excretion | Lymphatic clearance |

• Composition: A complex mixture of proteins, glycoproteins, and polysaccharides. Key allergens identified in coffee include various seed storage proteins.
• Solubility: The extract is typically prepared in an aqueous saline solution or a 50% glycerin/saline mixture.
• Molecular Weight: Ranges from <10 kDa to >70 kDa for the various protein fractions.

Coffea Arabica Seed, Roasted is classified as a Non-Standardized Food Allergenic Extract. It is grouped with other plant-derived extracts used for diagnostic purposes. It shares clinical characteristics with other bean/legume extracts but is unique due to the roasting-induced chemical changes (neo-allergens) that define its profile.